Davis SJ

cardiology research, beta-blockers, BBs, bisoprolol, carvedilol, metoprolol succinate, heart failure, HF, National Clinical Practice Guidelines, mortality, ventricular ejection fraction, EF, angiotensin converting enzyme inhibitors, ACEIs, angiotensin II receptor blockers, ARBs, diuretics, aldosterone antagonists, digitalis, hydralazine/nitrates, Veterans Health Administration Pharmacy Benefits Management Service and the Medical Advisory Panel, VHA PBM-MAP, electronic medical record, EMR, medication use evaluation, MUE, SAVAHCS Research and Development Committee, University of Arizona Institutional Review Board, International Classification of Disease 9th Clinical Modification, ICD-9, Care Coordination Home Telehealth program, CCHT cardiology research, beta-blockers, BBs, bisoprolol, carvedilol, metoprolol succinate, heart failure, HF, National Clinical Practice Guidelines, mortality, ventricular ejection fraction, EF, angiotensin converting enzyme inhibitors, ACEIs, angiotensin II receptor blockers, ARBs, diuretics, aldosterone antagonists, digitalis, hydralazine/nitrates, Veterans Health Administration Pharmacy Benefits Management Service and the Medical Advisory Panel, VHA PBM-MAP, electronic medical record, EMR, medication use evaluation, MUE, SAVAHCS Research and Development Committee, University of Arizona Institutional Review Board, International Classification of Disease 9th Clinical Modification, ICD-9, Care Coordination Home Telehealth program, CCHT

cardiology research, beta-blockers, BBs, bisoprolol, carvedilol, metoprolol succinate, heart failure, HF, National Clinical Practice Guidelines, mortality, ventricular ejection fraction, EF, angiotensin converting enzyme inhibitors, ACEIs, angiotensin II receptor blockers, ARBs, diuretics, aldosterone antagonists, digitalis, hydralazine/nitrates, Veterans Health Administration Pharmacy Benefits Management Service and the Medical Advisory Panel, VHA PBM-MAP, electronic medical record, EMR, medication use evaluation, MUE, SAVAHCS Research and Development Committee, University of Arizona Institutional Review Board, International Classification of Disease 9th Clinical Modification, ICD-9, Care Coordination Home Telehealth program, CCHT cardiology research, beta-blockers, BBs, bisoprolol, carvedilol, metoprolol succinate, heart failure, HF, National Clinical Practice Guidelines, mortality, ventricular ejection fraction, EF, angiotensin converting enzyme inhibitors, ACEIs, angiotensin II receptor blockers, ARBs, diuretics, aldosterone antagonists, digitalis, hydralazine/nitrates, Veterans Health Administration Pharmacy Benefits Management Service and the Medical Advisory Panel, VHA PBM-MAP, electronic medical record, EMR, medication use evaluation, MUE, SAVAHCS Research and Development Committee, University of Arizona Institutional Review Board, International Classification of Disease 9th Clinical Modification, ICD-9, Care Coordination Home Telehealth program, CCHT

cardiology research, beta-blockers, BBs, bisoprolol, carvedilol, metoprolol succinate, heart failure, HF, National Clinical Practice Guidelines, mortality, ventricular ejection fraction, EF, angiotensin converting enzyme inhibitors, ACEIs, angiotensin II receptor blockers, ARBs, diuretics, aldosterone antagonists, digitalis, hydralazine/nitrates, Veterans Health Administration Pharmacy Benefits Management Service and the Medical Advisory Panel, VHA PBM-MAP, electronic medical record, EMR, medication use evaluation, MUE, SAVAHCS Research and Development Committee, University of Arizona Institutional Review Board, International Classification of Disease 9th Clinical Modification, ICD-9, Care Coordination Home Telehealth program, CCHT cardiology research, beta-blockers, BBs, bisoprolol, carvedilol, metoprolol succinate, heart failure, HF, National Clinical Practice Guidelines, mortality, ventricular ejection fraction, EF, angiotensin converting enzyme inhibitors, ACEIs, angiotensin II receptor blockers, ARBs, diuretics, aldosterone antagonists, digitalis, hydralazine/nitrates, Veterans Health Administration Pharmacy Benefits Management Service and the Medical Advisory Panel, VHA PBM-MAP, electronic medical record, EMR, medication use evaluation, MUE, SAVAHCS Research and Development Committee, University of Arizona Institutional Review Board, International Classification of Disease 9th Clinical Modification, ICD-9, Care Coordination Home Telehealth program, CCHT